Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AXIS 2: AX200 for the treatment of ischemic stroke
2008-006444-19Phase 2Completed
- Sponsor
- Lion Bioscience
- Start
- Feb 2009
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in ischemic stroke comparing AX200 arm with Placebo arm (2 arms). Started Feb 2009; status: completed.
02
Drugs
filgrastim
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on 2008-006444-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-006444-19.